ADHEPTA Study: Adherence Questionnaire in Hepatitis C
ADHEPTA
Development and Validation of a Questionnaire Measuring Treatment Adherence in Patients With Hepatitis C
1 other identifier
observational
1,120
1 country
1
Brief Summary
Main objective: To study and validate a questionnaire measuring treatment adherence in patients with Hepatitis C virus (HCV) infection. Design of the study: Multicentric, prospective, epidemiological study in the field of usual clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2009
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
October 19, 2009
CompletedFirst Posted
Study publicly available on registry
October 20, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedOctober 16, 2015
October 1, 2009
11 months
October 19, 2009
October 14, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Main objective of the study is the development and validation of a Questionnaire measuring treatment adherence in patients with HCV infection.
2 years
Secondary Outcomes (2)
Adherence will be measured according to 80/80/80 rule.
2 years
Establish a relationship between adherence, virological response (VR) and Sustained virological response (SVR).
2 years
Study Arms (2)
Hepatitis C infection
Hepatitis C + HIV infections
Interventions
Adherence questionnaire
Eligibility Criteria
Patients with HCV and with HCV + HIV
You may qualify if:
- Ambulatory patient infected by HCV according to diagnosis criteria used en usual clinical practice.
- Patient no treated previously and beginning a treatment for HCV.
- Patient that signed the informed consent to participate in the study.
- Group A: patient with HCV monoinfection.
- Group B: patient with HCV and HCV co-infection (according to diagnosis criteria used en usual clinical practice).
You may not qualify if:
- Patient that received previous treatment for HCV.
- Patient that is going to participate in a clinical trial Turing the HCV treatment period.
- Patient with cognitive impairment or patient unable to understand and answer the auto-administered questionnaire.
- Patient unable to read or write Spanish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fundacion IMIMlead
Study Sites (1)
Hospital del Mar
Barcelona, Barcelona, 08003, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 19, 2009
First Posted
October 20, 2009
Study Start
October 1, 2009
Primary Completion
September 1, 2010
Study Completion
January 1, 2013
Last Updated
October 16, 2015
Record last verified: 2009-10